Liquidia (LQDA) Change in Receivables (2021 - 2026)
Liquidia (LQDA) posted Change in Receivables of $34.4 million for Q2 2026, up 71.59% on a QoQ basis from $20.1 million in Q1 2026, and up 294.76% year-over-year from $8.7 million in Q2 2025.
Analysis
Liquidia (LQDA) Change in Receivables (2021 - 2026) Analysis & Trends
Liquidia has reported Change in Receivables for 6 years, with the latest figure at $34.4 million in Q2 2026.
- On a quarterly basis, Change in Receivables rose 294.76% year-over-year to $34.4 million in Q2 2026; TTM through Jun 2026 was $98.6 million, a 1367.72% increase from a year earlier, with the FY2025 full-year figure at $51.4 million, up 3928.17% from the prior year.
- Change in Receivables was $34.4 million for Q2 2026 at Liquidia, up from $20.1 million in the prior quarter.
- The five-year high for Change in Receivables was $34.4 million in Q2 2026, with the low at -$1.5 million in Q1 2024.
- Average Change in Receivables over 5 years is $5.9 million, with a median of $572500.0 recorded in 2022.
- The largest YoY upside for Change in Receivables was 3235.0% in 2022 against a maximum downside of 1163.79% in 2022.
- Over 5 years, Change in Receivables stood at $1.9 million in 2022, then sank by 61.56% to $723000.0 in 2023, then slumped by 305.12% to -$1.5 million in 2024, then surged by 1322.79% to $18.1 million in 2025, then jumped by 89.85% to $34.4 million in 2026.
- The last three Change in Receivables figures came in at $34.4 million (Q2 2026), $20.1 million (Q1 2026), and $18.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | - |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | 73.80 Mn |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | -1.70 Mn |
| 10 | Liquidia | 6.09 Bn | 5.80 Bn | 160.92 Mn | 34.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.43 Mn |
| Mar 31, 2026 | 20.06 Mn |
| Dec 31, 2025 | 18.13 Mn |
| Sep 30, 2025 | 25.99 Mn |
| Jun 30, 2025 | 8.72 Mn |
| Mar 31, 2025 | -1.47 Mn |
| Dec 31, 2024 | -1.48 Mn |
| Sep 30, 2024 | 953,000.00 |
| Jun 30, 2024 | 679,000.00 |
| Mar 31, 2024 | -1.49 Mn |
| Dec 31, 2023 | 723,000.00 |
| Sep 30, 2023 | -757,000.00 |
| Jun 30, 2023 | -36,000.00 |
| Mar 31, 2023 | -886,000.00 |
| Dec 31, 2022 | 1.88 Mn |
| Sep 30, 2022 | -617,000.00 |
| Jun 30, 2022 | 466,000.00 |
| Mar 31, 2022 | 297,000.00 |
| Dec 31, 2021 | -60,000.00 |
| Sep 30, 2021 | 58,000.00 |